{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:54:35Z","timestamp":1780044875705,"version":"3.53.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00023"],"award-info":[{"award-number":["PI21\/00023"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/00412"],"award-info":[{"award-number":["PI13\/00412"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/01191"],"award-info":[{"award-number":["PI11\/01191"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI19\/00229"],"award-info":[{"award-number":["FI19\/00229"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010154","name":"Fundaci\u00f3n P\u00fablica Andaluza para la Gesti\u00f3n de la Investigaci\u00f3n en Salud de Sevilla","doi-asserted-by":"publisher","award":["PI-0102-2011"],"award-info":[{"award-number":["PI-0102-2011"]}],"id":[{"id":"10.13039\/100010154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRYES223070FERR"],"award-info":[{"award-number":["PRYES223070FERR"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2021 SGR 00624"],"award-info":[{"award-number":["2021 SGR 00624"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018967","name":"Universitat Pompeu Fabra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To assess the validity, reliability, and responsiveness of the Spanish version of the Expanded Prostate cancer Index Composite (EPIC) with 26 items.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Multicentric longitudinal study of patients diagnosed with localized or locally advanced prostate cancer (any T, any N, M0) treated with active surveillance, surgery, external radiotherapy, or brachytherapy. The EPIC-50 was administered initially to the cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009324 patients), until it was replaced in November 2019 by the EPIC-26 (<jats:italic>n<\/jats:italic>\u2009=\u2009543), in both groups before treatment and 12\u00a0months after. We assessed confirmatory factor analysis (CFA), reliability with Cronbach\u2019s alpha coefficient, criterion validity with the intraclass correlation coefficient (ICC), and responsiveness by testing a priori hypotheses on deterioration effect size (ES).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The CFA confirmed the five-domain structure of the EPIC-26 proposed by the original instrument (comparative fit index\u2009=\u20090.95). The agreement between EPIC-50 (gold standard) and EPIC-26 domains was excellent (ICC\u2009&gt;\u20090.90). Cronbach\u2019s alpha was\u2009&gt;\u20090.7 in almost all domains, and the floor effect was near zero, although ceiling effect was higher than 50% in urinary incontinence and bowel domains. Hypothesized changes between before and 12\u00a0months after treatment were confirmed: ES\u2009&gt;\u20090.8 in both urinary incontinence and sexual domains among patients who underwent surgery; and ES ranging 0.44\u20130.48 for bowel and sexual domains\u00a0in patients treated with external radiotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The Spanish version of the EPIC-26 has demonstrated adequate metric properties, similar to those of the original version, with acceptable goodness-of-fit indices, good criterion validity, reliability, and responsiveness to detect changes after radical prostatectomy or external radiotherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-023-04691-7","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T14:02:21Z","timestamp":1699624941000},"page":"3511-3518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Psychometric validation of the Spanish version of the Expanded Prostate Cancer Index Composite-26"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2061-0052","authenticated-orcid":false,"given":"V\u00edctor","family":"Zamora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-0779","authenticated-orcid":false,"given":"Olatz","family":"Garin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-4391","authenticated-orcid":false,"given":"Jos\u00e9 Francisco","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0196-0372","authenticated-orcid":false,"given":"Josep","family":"Jov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2370-2008","authenticated-orcid":false,"given":"Manuel","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-0967","authenticated-orcid":false,"given":"Ferran","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6944-772X","authenticated-orcid":false,"given":"Cristina","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8798-8696","authenticated-orcid":false,"given":"Ferran","family":"Guedea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-8014","authenticated-orcid":false,"given":"Ana","family":"Boladeras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3996-167X","authenticated-orcid":false,"given":"Lluis","family":"Fumad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-2890","authenticated-orcid":false,"given":"Alvar","family":"Rosell\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4693-1041","authenticated-orcid":false,"given":"Jorge","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-6431","authenticated-orcid":false,"given":"Pilar","family":"Samper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0602-552X","authenticated-orcid":false,"given":"\u00c0ngels","family":"Pont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-7391","authenticated-orcid":false,"given":"Montse","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"issue":"3","key":"4691_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4691_CR2","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/jnci\/djp262","volume":"101","author":"YH Shao","year":"2009","unstructured":"Shao YH, Demissie K, Shih W et al (2009) Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 101:1280\u20131283. https:\/\/doi.org\/10.1093\/jnci\/djp262","journal-title":"J Natl Cancer Inst"},{"key":"4691_CR3","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7326\/0003-4819-155-11-201112060-00375","volume":"155","author":"R Chou","year":"2011","unstructured":"Chou R, Croswell JM, Dana T et al (2011) Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 155:762\u2013771. https:\/\/doi.org\/10.7326\/0003-4819-155-11-201112060-00375","journal-title":"Ann Intern Med"},{"issue":"15","key":"4691_CR4","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane JA et al (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375(15):1425\u20131437. https:\/\/doi.org\/10.1056\/NEJMoa1606221","journal-title":"N Engl J Med"},{"issue":"2","key":"4691_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.radonc.2013.05.038","volume":"108","author":"M Ferrer","year":"2013","unstructured":"Ferrer M, Guedea F, Su\u00e1rez JF et al (2013) Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up. Radiother Oncol 108(2):306\u2013313. https:\/\/doi.org\/10.1016\/j.radonc.2013.05.038","journal-title":"Radiother Oncol"},{"issue":"3","key":"4691_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.eururo.2014.08.075","volume":"67","author":"NE Martin","year":"2015","unstructured":"Martin NE, Massey L, Stowell C et al (2015) Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol 67(3):460\u2013467. https:\/\/doi.org\/10.1016\/j.eururo.2014.08.075","journal-title":"Eur Urol"},{"issue":"8","key":"4691_CR7","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s11136-014-0678-8","volume":"23","author":"S Schmidt","year":"2014","unstructured":"Schmidt S, Garin O, Pardo Y et al (2014) Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments. Qual Life Res 23(8):2169\u20132181. https:\/\/doi.org\/10.1007\/s11136-014-0678-8","journal-title":"Qual Life Res"},{"issue":"2","key":"4691_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.euo.2021.10.004","volume":"5","author":"MM Ratti","year":"2022","unstructured":"Ratti MM, Gandaglia G, Alleva E et al (2022) Standardising the assessment of patient-reported outcome measures in localised prostate cancer. A systematic review. Eur Urol Oncol 5(2):153\u2013163. https:\/\/doi.org\/10.1016\/j.euo.2021.10.004","journal-title":"Eur Urol Oncol"},{"key":"4691_CR9","doi-asserted-by":"publisher","first-page":"899e905","DOI":"10.1016\/s0090-4295(00)00858-x","volume":"56","author":"JT Wei","year":"2000","unstructured":"Wei JT, Dunn RL, Litwin MS et al (2000) Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56:899e905. https:\/\/doi.org\/10.1016\/s0090-4295(00)00858-x","journal-title":"Urology"},{"issue":"5","key":"4691_CR10","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.urology.2010.01.027","volume":"76","author":"KM Szymanski","year":"2010","unstructured":"Szymanski KM, Wei JT, Dunn RL, Sanda MG (2010) Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology 76(5):1245\u20131250. https:\/\/doi.org\/10.1016\/j.urology.2010.01.027","journal-title":"Urology"},{"issue":"1","key":"4691_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12894-017-0302-7","volume":"17","author":"K Axcrona","year":"2017","unstructured":"Axcrona K, Nilsson R, Brennhovd B et al (2017) Psychometric properties of the expanded prostate cancer index composite \u2013 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations. BMC Urol 17(1):111. https:\/\/doi.org\/10.1186\/s12894-017-0302-7","journal-title":"BMC Urol"},{"issue":"6","key":"4691_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.jpainsymman.2017.02.010","volume":"53","author":"WWT Lam","year":"2017","unstructured":"Lam WWT, Tse MA, Ng CNL, Chung EKM, Fielding R (2017) Psychometric Assessment of the Chinese Version of the Abbreviated Expanded Prostate Cancer Index Composite (EPIC-26) and the Clinical Practice Version (EPIC-CP) in Chinese men with prostate cancer. J Pain Symptom Manag 53(6):1085\u20131090. https:\/\/doi.org\/10.1016\/j.jpainsymman.2017.02.010","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"4691_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00345-019-02949-7","volume":"39","author":"NT Sibert","year":"2019","unstructured":"Sibert NT, Dieng S, Oesterle A et al (2019) Psychometric validation of the German version of the EPIC-26 questionnaire for patients with localized and locally advanced prostate cancer. World J Urol 39(1):11\u201325. https:\/\/doi.org\/10.1007\/s00345-019-02949-7","journal-title":"World J Urol"},{"issue":"1","key":"4691_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12955-019-1214-x","volume":"17","author":"C Marzorati","year":"2019","unstructured":"Marzorati C, Monzani D, Mazzocco K et al (2019) Validation of the Italian version of the abbreviated expanded prostate cancer index composite (EPIC-26) in men with prostate Cancer. Health Qual Life Outcomes 17(1):147. https:\/\/doi.org\/10.1186\/s12955-019-1214-x","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"4691_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5489\/cuaj.5997","volume":"14","author":"RT Crump","year":"2020","unstructured":"Crump RT, Peterson A, Charbonneau C et al (2020) Evaluating the measurement properties of the 26-item Expanded Prostate Cancer Index Composite (EPIC-26) with a multicenter cohort. Can Urol Assoc J 14(4):111\u2013117. https:\/\/doi.org\/10.5489\/cuaj.5997","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"4691_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.ijrobp.2016.07.038","volume":"96","author":"JY Lee","year":"2016","unstructured":"Lee JY, Daignault-Newton S, Heath G et al (2016) Multinational prospective study of patient-reported outcomes after prostate radiation therapy: detailed assessment of rectal bleeding. Int J Radiat Oncol Biol Phys 96(4):770\u2013777. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.07.038","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4691_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.medcli.2008.01.001","volume":"132","author":"M Ferrer","year":"2009","unstructured":"Ferrer M, Garin O, Pera J et al (2009) Evaluation of the quality of life of patients with localizad prostate cancer: validation of the Spanish version of the EPIC. Med Clin (Barc) 132(4):128\u2013135. https:\/\/doi.org\/10.1016\/j.medcli.2008.01.001","journal-title":"Med Clin (Barc)"},{"issue":"11","key":"4691_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017006","volume":"7","author":"SM Evans","year":"2017","unstructured":"Evans SM, Millar JL, Moore CM et al (2017) Cohort profile: the TrueNTH Global Registry: an international registry to monitor and improve localized prostate cancer health outcomes. BMJ Open 7(11):e017006. https:\/\/doi.org\/10.1136\/bmjopen-2017-017006","journal-title":"BMJ Open"},{"issue":"2","key":"4691_CR19","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2002.20.2.557","volume":"20","author":"JT Wei","year":"2002","unstructured":"Wei JT, Dunn RL, Sandler HM et al (2002) Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20(2):557\u2013566. https:\/\/doi.org\/10.1200\/JCO.2002.20.2.557","journal-title":"J Clin Oncol"},{"key":"4691_CR20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF02310555","volume":"16","author":"LJ Cronbach","year":"1951","unstructured":"Cronbach LJ (1951) Coefficient alpha and the internal structure of tests. Psychometrika 16:297\u2013334. https:\/\/doi.org\/10.1007\/BF02310555","journal-title":"Psychometrika"},{"issue":"1","key":"4691_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10705519909540118","volume":"6","author":"L Hu","year":"1999","unstructured":"Hu L, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model A Multidiscip J 6(1):1\u201355. https:\/\/doi.org\/10.1080\/10705519909540118","journal-title":"Struct Equ Model A Multidiscip J"},{"issue":"2","key":"4691_CR22","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"4691_CR23","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences. N.J.L. Erlbaum Associates, Hillsdale"},{"issue":"3","key":"4691_CR24","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ijrobp.2020.12.032","volume":"110","author":"O Garin","year":"2021","unstructured":"Garin O, Su\u00e1rez JF, Guedea F et al (2021) Comparative effectiveness research in localized prostate cancer: a 10-year follow-up cohort study. Int J Radiat Oncol Biol Phys 110(3):718\u2013726. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.12.032","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4691_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/bju.13843","volume":"120","author":"GW Chien","year":"2017","unstructured":"Chien GW, Slezak JM, Harrison TN et al (2017) Health-related quality of life outcomes from a contemporary prostate cancer registry in a large diverse population. BJU Int 120(4):520\u2013529. https:\/\/doi.org\/10.1111\/bju.13843","journal-title":"BJU Int"},{"issue":"1","key":"4691_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 60(1):34\u201342. https:\/\/doi.org\/10.1016\/j.jclinepi.2006.03.012","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"4691_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2217\/cer.14.41","volume":"3","author":"D Chu","year":"2014","unstructured":"Chu D, Popovic M, Chow E et al (2014) Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res 3(5):523\u2013531. https:\/\/doi.org\/10.2217\/cer.14.41","journal-title":"J Comp Eff Res"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04691-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-023-04691-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-023-04691-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T12:06:03Z","timestamp":1701518763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-023-04691-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":27,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1007\/s00345-023-04691-7","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Olatz Garin and Montse Ferrer certify that all conflicts of interest including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g., employment\/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study has been reviewed and approved by the Institutional Review Board at the Hospital del Mar Medical Research Institute, in accordance with the 2000 Declaration of Helsinki. The study was also approved by the ethics committees from the participating sites: Institut Catal\u00e0 d\u2019Oncologia-L\u2019Hospitalet, Hospital Regional Universitario de M\u00e1laga, Hospital Universitari de Bellvitge, Hospital del Mar, Hospital Provincial de Castell\u00f3n, Hospital Universitario Central de Asturias, Hospital Universitario Rey Juan Carlos, Hospital Universitario de Salamanca, Hospital General Universitario de Ciudad Real, Institut Catal\u00e0 d\u2019Oncologia-Badalona, Hospital Universitario de Navarra, Hospital General Universitario de Valencia, Hospital de la Santa Creu i Sant Pau, Hospital do Meixoeiro, Hospital Universitario Reina Sof\u00eda, and Hospital General Universitario de Albacete. Written informed consent was provided by all subjects when they were enrolled.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}